Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (73 total)
-
Créateur: the GS-US-540-5773 Investigators
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-11-05
Description: We conducted a randomized, open-label, phase 3 trial involving hospitalized patients with confirmed SARS-CoV-2 infection, oxygen saturation of 94% or less while they were breathing ambient air, and radiologic evidence of pneumonia. -
Créateur: the ACTT-1 Study Group Members
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-11-05
Description: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.A response to this article was published:Dolin, Raphael,… -
Créateur: Goepfert, Paul A., Bo Fu, Anne-Laure Chabanon, Matthew I. Bonaparte, Matthew G. Davis, Brandon J. Essink, Ian Frank, Owen Haney, Helene Janosczyk, Michael C. Keefer, Marguerite Koutsoukos, Murray A. Kimmel, Roger Masotti, Stephen J. Savarino, Lode…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-19
Description: CoV2 preS dTM is a stabilised pre-fusion spike protein vaccine produced in a baculovirus expression system being developed against SARS-CoV-2. We present interim safety and immunogenicity results of the first-in-human study of the CoV2 preS dTM… -
Créateur: Barda, Noam, Noa Dagan, Yatir Ben-Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A. Hernán, Marc Lipsitch, Isaac Kohane, Doron Netzer, Ben Y. Reis, and Ran D. Balicer.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-08-25
Description: Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these trials were subject to size and patient-mix limitations. An evaluation of the… -
Créateur: Keehner, Jocelyn, Lucy E. Horton, Michael A. Pfeffer, Christopher A. Longhurst, Robert T. Schooley, Judith S. Currier, Shira R. Abeles, and Francesca J. Torriani.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-23
Description: Data from phase 3 clinical trials of messenger RNA (mRNA) vaccines through November 2020 showed 94.1% efficacy for the prevention of symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at 14 days after the second dose…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: the Siren Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-09
Description: Increased understanding of whether individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to investigate whether antibodies against SARS-CoV-2 were associated with a decreased… -
Créateur: Braun, Fabian, Marc Lütgehetmann, Susanne Pfefferle, Milagros N. Wong, Alexander Carsten, Maja T. Lindenmeyer, Dominik Nörz, Fabian Heinrich, Kira Meißner, Dominic Wichmann, Stefan Kluge, Oliver Gross, Klaus Pueschel, Ann S. Schröder, Carolin Edler,…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-08-17
Description: Acute kidney injury is a commonly described complication of COVID-19 that has been linked to increased morbidity and mortality. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been found in the kidney, the clinical effect… -
Créateur: Bhopal, Sunil S., and Raj Bhopal.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-08-13
Description: In the COVID-19 pandemic, we have emphasised the importance for epidemiological data to be presented by age and sex groups. -
Créateur: Xydakis, Michael S., Puya Dehgani-Mobaraki, Eric H. Holbrook, Urban W. Geisthoff, Christian Bauer, Charlotte Hautefort, Philippe Herman, Geoffrey T. Manley, Dina M. Lyon, and Claire Hopkins.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-15
Description: The plural of an anecdote is not evidence, yet anecdotal international reports are accumulating from ear, nose, and throat (ENT) surgeons and other health-care workers on the front lines that anosmia, with or without dysgeusia, are symptoms… -
Créateur: Schultz, Nina H., Ingvild H. Sørvoll, Annika E. Michelsen, Ludvig A. Munthe, Fridtjof Lund-Johansen, Maria T. Ahlen, Markus Wiedmann, Anne-Hege Aamodt, Thor H. Skattør, Geir E. Tjønnfjord, and Pål A. Holme.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-09
Description: We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19).